Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limitedverified

0950.HK

Price:

$1.66

Market Cap:

$977.47M

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. The company focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. It operates through Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells self-developed and generic pharmaceutical products, such as Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Eyprotor for corneal ulc...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2002-07-15

Stock Exchange

HKSE

Ticker

0950.HK

The Enterprise Value as of December 2025 (TTM) for Lee's Pharmaceutical Holdings Limited (0950.HK) is 917.52M

According to Lee's Pharmaceutical Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 917.52M. This represents a change of 15.17% compared to the average of 796.70M of the last 4 quarters.

Lee's Pharmaceutical Holdings Limited (0950.HK) Historical Enterprise Value (quarterly & annually)

How has 0950.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Lee's Pharmaceutical Holdings Limited over the last ten years is 2.45B. The current 917.52M Enterprise Value has changed 3.65% with respect to the historical average. Over the past ten years (40 quarters), 0950.HK's Enterprise Value was at its highest in in the March 2018 quarter at 6.33B. The Enterprise Value was at its lowest in in the September 2015 quarter at 0.

Quarterly (TTM)
Annual

Average

2.45B

Median

2.26B

Minimum

846.64M

Maximum

5.26B

Lee's Pharmaceutical Holdings Limited (0950.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lee's Pharmaceutical Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 24.84%

Maximum Annual Enterprise Value = 5.26B

Minimum Annual Increase = -52.10%

Minimum Annual Enterprise Value = 846.64M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024846.64M-6.41%
2023904.62M-3.15%
2022933.99M-52.10%
20211.95B-22.20%
20202.51B24.84%
20192.01B-32.09%
20182.96B-21.38%
20173.76B12.98%
20163.33B-36.73%
20155.26B-9.37%

Lee's Pharmaceutical Holdings Limited (0950.HK) Average Enterprise Value

How has 0950.HK Enterprise Value performed in the past?

The current Enterprise Value of Lee's Pharmaceutical Holdings Limited (0950.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

895.08M

5-year avg

1.43B

10-year avg

2.45B

Lee's Pharmaceutical Holdings Limited (0950.HK) Enterprise Value vs. Peers

How is 0950.HK’s Enterprise Value compared to its peers?

Lee's Pharmaceutical Holdings Limited’s Enterprise Value is greater than Jilin Province Huinan Changlong Bio-pharmacy Company Limited (692.18M), greater than Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (-136251613.00), greater than EuroEyes International Eye Clinic Limited (623.63M), greater than Pak Fah Yeow International Limited (437.02M), less than Venus Medtech (Hangzhou) Inc. (1.19B), less than Arrail Group Limited (1.42B), less than Tian An Medicare Limited (1.17B), greater than Sirnaomics Ltd. (111.01M), greater than Chia Tai Enterprises International Limited (445.45M), less than Gaush Meditech Ltd (1.31B),

Build a custom stock screener for Lee's Pharmaceutical Holdings Limited (0950.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lee's Pharmaceutical Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lee's Pharmaceutical Holdings Limited (0950.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lee's Pharmaceutical Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Lee's Pharmaceutical Holdings Limited's Enterprise Value?

What is the highest Enterprise Value for Lee's Pharmaceutical Holdings Limited (0950.HK)?

What is the 3-year average Enterprise Value for Lee's Pharmaceutical Holdings Limited (0950.HK)?

What is the 5-year average Enterprise Value for Lee's Pharmaceutical Holdings Limited (0950.HK)?

How does the current Enterprise Value for Lee's Pharmaceutical Holdings Limited (0950.HK) compare to its historical average?